| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |